Response-based chemotherapy and involved field radiation for intermediate stage Hodgkin disease. A GISL/NHLSG trial

被引：0
|
作者：
Iannitto, E. [1 ]
Minardi, V. [1 ]
Gobbi, P. G. [2 ]
Luminari, S. [3 ]
Calvaruso, G. [1 ]
Stelitano, C. [4 ]
Baldini, L. [5 ]
Merli [6 ]
Petrini, M. [7 ]
Marcheselli, L. [3 ]
Mammi, C. [3 ]
De Cantis, S. [1 ]
Abbadessa, V [1 ]
Federico, M. [3 ]
机构：
[1] Univ Palermo, I-90133 Palermo, Italy
[2] Univ Pavia, I-27100 Pavia, Italy
[3] Univ Modena & Reggio Emilia, Dept Hematol & Oncol, Modena, Italy
[4] Osped Bianchi Melacrino Morelli, Reggio Di Calabria, Italy
[5] Univ Milan, Dipartimento Ematol, I-20122 Milan, Italy
[6] Osped SM Nuova, Reggio Emilia, Italy
[7] Univ Pisa, I-56100 Pisa, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [1] Response-based chemotherapy and involved field radiation for intermediate stage Hodgkin disease. A GISL/NHLSG trial.
    Iannitto, Emilio
    Minardi, Viviana
    Gobbi, Paolo G.
    Calvaruso, Giuseppina
    Stelitano, Caterina
    Baldini, Luca
    Merli, Francesco
    Petrini, Mario
    Marcheselli, Luigi
    Mammi, Caterina
    De Cantis, Stefano
    Abbadessa, Vincenzo
    Federico, Massimo
    BLOOD, 2006, 108 (11) : 701A - 701A
  • [2] Response-Guided ABVD Chemotherapy plus Involved-Field Radiation Therapy for Intermediate-Stage Hodgkin Lymphoma in the Pre-Positron Emission Tomography Era: A Gruppo Italiano Studio Linfomi (GISL) Prospective Trial
    Iannitto, Emilio
    Minardi, Viviana
    Gobbi, Paolo G.
    Calvaruso, Giuseppina
    Tripodo, Claudio
    Marclieselli, Luigi
    Luminari, Stefano
    Merli, Francesco
    Baldini, Luca
    Stelitano, Caterina
    Callea, Vincenzo
    Petrini, Mario
    Angrilli, Francesco
    Quarta, Giovanni
    Vallisa, Daniele
    Molica, Stefano
    Liardo, Eliana
    Polimeno, Giuseppe
    Brugiatelli, Maura
    Federico, Massimo
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (02): : 138 - 144
  • [3] Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease
    Subbiah, Vivek
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (07): : 743 - 743
  • [4] Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease
    Ferme, Christophe
    Eghbali, Houchingue
    Meerwaldt, Jacobus H.
    Rieux, Chantal
    Bosq, Jacques
    Berger, Francoise
    Girinsky, Theodore
    Brice, Pauline
    van't Veer, Mars B.
    Walewski, Jan A.
    Lederlin, Pierre
    Tirelli, Umberto
    Carde, Patrice
    Van den Neste, Eric
    Gyan, Emmanuel
    Monconduit, Mathieu
    Divine, Marine
    Raemaekers, John M. M.
    Salles, Gilles
    Noordijk, Evert M.
    Creemers, Geert-Jan
    Gabarre, Jean
    Hagenbeek, Anton
    Reman, Oumedaly
    Blanc, Michel
    Thomas, Jose
    Vie, Brigitte
    Kluin-Nelemans, Johanna C.
    Viseu, Fernando
    Baars, Joke W.
    Poortmans, Philip
    Lugtenburg, Pieternella J.
    Carrie, Christian
    Jaubert, Jerome
    Henry-Amar, Michel
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (19): : 1916 - 1927
  • [5] For intermediate stage Hodgkin's disease extended field radiation after effective chemotherapy is obsolete:: Interim analysis of the HD9 trial (GHSG).
    Rüffer, JU
    Sieber, M
    Pfistner, B
    Tesch, H
    Engert, A
    Bredenfeld, H
    Breuer, K
    Herrmann, R
    Koch, P
    Boissevain, F
    Zschaber, R
    Löffler, M
    Diehl, V
    BLOOD, 1999, 94 (10) : 528A - 528A
  • [6] Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease
    Hudson, MM
    Krasin, M
    Link, MP
    Donaldson, SS
    Billups, C
    Merchant, TE
    Kun, L
    Billet, AL
    Kaste, S
    Tarbell, NJ
    Howard, S
    Friedmann, AM
    Hurwitz, CA
    Young, JA
    Marcus, KC
    Rai, S
    Cowan, T
    Weinstein, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) : 4541 - 4550
  • [7] Excellent Outcomes Following Response-Based Omission of Radiotherapy in Children and Adolescents with Intermediate or Advanced Stage Hodgkin Lymphoma
    Ozuah, Nmazuo
    Marcus, Karen
    LaCasce, Ann
    Billett, Amy
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S3 - S3
  • [8] VAMP chemotherapy and low dose involved Field (IF) irradiation for early stage Hodgkin's disease
    Weinstein, HJ
    Hodson, M
    Link, MP
    Billett, AL
    Kun, L
    Tarbell, NJ
    Donaldson, SS
    PEDIATRIC RESEARCH, 2000, 47 (04) : 254A - 254A
  • [9] Early-stage Hodgkin's disease (ESHD) treated with radiotherapy involved field (IFRT) and chemotherapy
    Santoro, M.
    Scalzo, C.
    Pingitore, A.
    Squillace, R.
    Molica, S.
    Prantera, T.
    Cicero, G.
    Condemi, G.
    Pingitore, D.
    ANNALS OF ONCOLOGY, 2006, 17 : XI58 - XI58
  • [10] Early-stage Hodgkin's disease (ESHD) treated with involved field radiotherapy (IFRT) and chemotherapy
    Santoro, M.
    Falcone, S.
    Riccelli, R.
    Colosimo, A.
    Ianni, R.
    Pingitore, D.
    ANNALS OF ONCOLOGY, 2005, 16 : 151 - 151
12345